We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

COVID-19 Screening definition

COVID-19 Screening. Because COVID-19 infections have been confirmed throughout the United States, including in the State of California and Orange County, and in an effort to prevent the spread of COVID- 19 and reduce the risk of exposure to Activity staff and participants, please complete this short screening questionnaire. Within the past 14 days have you travelled internationally or to any other state?  YES  NO Participant Initials: Within the past 14 days have you had close contact with or cared for someone who has been diagnosed with COVID-19 or suspected to have COVID-19?  YES  NO Participant Initials: Within the past 24 hours have you experienced any of the following symptoms: fever, cough, shortness of breath, difficulty breathing, chills, muscle pain, sore throat, new loss of taste or smell?  YES  NO Participant Initials:
COVID-19 Screening. Because COVID-19 infections have been confirmed throughout the United States, including in the State of California and Los Angeles County, and in an effort to prevent the spread of COVID-19 and reduce the risk of exposure to Activity staff and participants, please complete this short screening questionnaire. o YES o NO Participant Initials: Within the past 14 days have you had close contact with or cared for someone who has been diagnosed with COVID-19 or suspected to have COVID-19? o YES o NO Participant Initials: Within the past 24 hours have you experienced any of the following symptoms: fever, cough, shortness of breath, difficulty breathing, chills, muscle pain, sore throat, new loss of taste or smell? o YES o NO Participant Initials:

Examples of COVID-19 Screening in a sentence

  • In particular, Contractors are responsible for ensuring onsite personnel have gloves and masks available, screening all onsite personnel daily using the District’s COVID-19 Screening Form which includes symptomatic screening questions and a temperature check.

  • This response plan remains in force for as long as the declaration of a national disaster published in Government Gazette 43096 on 15 March 2020 remains in force General Precautionary Measures COVID-19 Screening Use checklists/Questionnaire completed daily by the employees that addresses symptoms of COVID-19 and where temperature measurements are noted.

  • Printed Materials: • COVID-19 Screening Checklist • DSHS-supplied Event Materials (Banners, Welcome Signs, Posters, etc.) • Event Signage • HIPAA Privacy Statement • ImmTrac2 Consent Forms • Emergency Use Authorization (EUA)/Vaccine Information Statement (VIS) • EUA/VIS Addendum.

  • Parents/guardians will also be asked to sign a COVID-19 Screening Agreement that was developed in partnership with the Lenawee County Health Department indicating that they will conduct a daily COVID-19 screening and that they will not send their child to school if the screening process detects any possibility that the child may have COVID-19 and/or that the child may have been exposed to COVID-19.

  • Pursuant to section 127A-11, HRS, all persons entering the State of Hawai‘i shall submit to the mandatory screening process and complete the mandatory documentation identified in the Rules Relating to COVID-19 Screening Process and Travel Self-Quarantine, attached hereto as Exhibit B and hereinafter referred to as the “Travel Rules,” and must comply with all applicable State and county rules, directives, and orders related to travelers.

  • Approved Licensed Provider: A licensed entity approved by MSM to conduct FDA-authorized COVID- 19 testing.MSM COVID-19 Assessment Form: COVID-19 Screening Questions accessible on the Campus Shield phone application.

  • Stock (2020): “Economic Benefits of COVID-19 Screening Tests,” medRxiv.Berger, D.

  • Daily Health Screening ● Prior to entering all District locations, both staff and students must complete a medical screening questionnaire and submit it through the COVID-19 Screening App being utilized by the District.● Paper copies of the questionnaire will also be available at check-in stations at the entrance to each building for visitors.● Staff will be required to monitor their own temperatures prior to arrival on campus and throughout the day.

  • COVID-19 Screening Decision Tree for K-12 & Daycare: Responding to Symptomatic Individuals.https://ldh.la.gov/assets/oph/Coronavirus/resources/ DecisionTree/Schools-DecisionTree.pdf.

  • COVID-19 SCREENING FLOWCHART OF FCSS STUDENTS ‌ Purpose: The COVID-19 Screening Flowchart of FCSS Students was designed to demonstrate the internal process when a student presents signs and symptoms of COVID-19 to a Health Office.

Related to COVID-19 Screening

  • Health screening means the use of one or more diagnostic tools to test a person for the presence or precursors of a particular disease.

  • Healing arts screening means the testing of human beings using x-ray machines for the detection or evaluation of health indications when such tests are not specifically and individually ordered by a licensed practitioner of the healing arts legally authorized to prescribe such x-ray tests for the purpose of diagnosis or treatment.

  • Screening means the process to determine whether the person seeking assistance needs further comprehensive assessment.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Alcohol Screening Device (ASD) means a breath or saliva device, other than an Evidential Breath Testing Device (EBT), that is approved by the National Highway Traffic Safety Administration and placed on its Conforming Products List for such devices.

  • COVID-19 means SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease outbreaks.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Biomarker means a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a specific therapeutic intervention. Biomarkers include, but are not limited to, gene mutations or protein expression.

  • COVID-19 test means a viral test for SARS-CoV-2 that is:

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • HCD means the California Department of Housing and Community Development.

  • Medical cannabis pharmacy means the same as that term is defined in Section 26-61a-102.

  • Drug therapy management means the review of a drug therapy regimen of a patient by one or more pharmacists for the purpose of evaluating and rendering advice to one or more practitioners regarding adjustment of the regimen.

  • obsrvd_agnt_cd ;"count erparty_identifier";"entty_rl";"cntrct_id";"instrmnt_id";" reporting_reference_date" Alpha-numeric Semicolon-separated string of all column names. Field names are put in double quotation marks. 1 reporting_agent_identifier Variable characters (60) 60 identifier domain 2 obsrvd_agnt_cd Variable characters (60) 60 identifier domain 3 counterparty_identifier Variable characters (60) 60 identifier domain 4 entty_rl Variable characters (25) 25 counterparty-instrument role type 5 cntrct_id Variable characters (60) 60 identifier domain 6 instrmnt_id Variable characters (60) 60 identifier domain 7 reporting_reference_date Date reporting reference date

  • Cannabinoid edible means food or potable liquid into which a cannabinoid concentrate, cannabinoid extract or dried marijuana leaves or flowers have been incorporated.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Hydraulic fracturing means the fracturing of underground rock formations, including shale and non-shale formations, by manmade fluid-driven techniques for the purpose of stimulating oil, natural gas, or other subsurface hydrocarbon production.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Dental laboratory means a person, firm or corporation

  • Diagnostic mammography means a method of screening that

  • Embryo/fetus means the developing human organism from conception until the time of birth.

  • Fluoroscopic imaging assembly means a subsystem in which X-ray photons produce a visual image. It includes the image receptor(s) such as the image intensifier and spot-film device, electrical interlocks, if any, and structural material providing linkage between the image receptor and diagnostic source assembly.

  • Screening Test Technician (STT) means anyone who instructs and assists individuals in the alcohol testing process and operates an ASD.